Comparing the PrePex™ Device to Surgical Circumcision for Rapid Scale Up of Male Circumcision in Resource Limited Setting

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Agnes Binagwaho M.D., Ministry of Health, Rwanda
ClinicalTrials.gov Identifier:
NCT01284088
First received: January 24, 2011
Last updated: March 14, 2012
Last verified: March 2012

January 24, 2011
March 14, 2012
January 2011
April 2011   (final data collection date for primary outcome measure)
The study's primary goal is to compare the PrePex™ circumcision procedure with one of the approved WHO methods of surgical circumcision. [ Time Frame: 9 weeks ] [ Designated as safety issue: No ]
The primary endpoint is the total operative time of the PrePex™ Device circumcision procedure versus the total operative time of surgical circumcision procedure.
The study's primary goal is to compare the PrePex™ circumcision procedure with one of the approved WHO methods of surgical circumcision. [ Time Frame: 9 weeks ] [ Designated as safety issue: No ]
The primary endpoint is the total operative time of the PrePex™ System circumcision procedure versus the total operative time of surgical circumcision procedure.
Complete list of historical versions of study NCT01284088 on ClinicalTrials.gov Archive Site
  • Measured circumcision preparation time. [ Time Frame: 9 weeks ] [ Designated as safety issue: No ]
    The total preparation time of the PrePex™ Device circumcision procedure versus the total preparation time of surgical circumcision procedure
  • Pain assessment at key time points [ Time Frame: 9 weeks ] [ Designated as safety issue: No ]
  • Clinical adverse event rates [ Time Frame: 9 weeks ] [ Designated as safety issue: Yes ]
  • Patient satisfaction [ Time Frame: 9 weeks ] [ Designated as safety issue: No ]
  • Time to complete healing [ Time Frame: 9 weeks ] [ Designated as safety issue: No ]
  • Measured circumcision preparation time. [ Time Frame: 9 weeks ] [ Designated as safety issue: No ]
    The total preparation time of the PrePex™ System circumcision procedure versus the total preparation time of surgical circumcision procedure
  • Pain assessment at key time points [ Time Frame: 9 weeks ] [ Designated as safety issue: No ]
  • Clinical adverse event rates [ Time Frame: 9 weeks ] [ Designated as safety issue: Yes ]
  • Patient satisfaction [ Time Frame: 9 weeks ] [ Designated as safety issue: No ]
  • Time to complete healing [ Time Frame: 9 weeks ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Comparing the PrePex™ Device to Surgical Circumcision for Rapid Scale Up of Male Circumcision in Resource Limited Setting
A Prospective, Randomized, Open Label, Trial Comparing the PrePex™ Device to Surgical Circumcision for Rapid Scale Up of Male Circumcision in Resource Limited Settings

The World Health Organization and UNAIDS cite that male circumcision can reduce the lifetime risk of HIV infection by 60% in high risk areas such as Sub Saharan Africa.

Rwanda has a national plan to offer a voluntary circumcision program to 2 million adult men in 2 years as part of a comprehensive HIV prevention package. To achieve this goal, the government is continuing to study the PrePex™ device, developed to enable rapid adult male circumcision in resource limited settings.

The study will enroll one hundred and fifty (150) persons scheduled for voluntary circumcision. The subjects will be randomly divided into two unbalanced study arms, PrePex™ arm which will include about a hundred and twenty (100) subjects and surgical circumcision arm which will include about sixty (50) subjects.

Study duration per subject will be 9 weeks.

The World Health Organization and UNAIDS cite that male circumcision can reduce the lifetime risk of HIV infection by 60% in high risk areas such as Sub Saharan Africa. In 2009, the US Government (USAID) reported that scaling up male circumcision to reach 80 percent of adult and newborn males in 14 African countries by 2015 could potentially avert more than 4 million adult HIV infections between 2009 and 2025 and yield annual cost savings of US$1.4 - 1.8 billion after 2015, with a total net savings of US$20.2 billion between 2009 and 2025.

There are over 38 million adolescent and adult males in Africa that could benefit from male circumcision for HIV prevention. The challenge Africa faces is how to safely scale up a surgical procedure in resources limited settings.

The government of Rwanda has a national plan to decrease the incidence rate of HIV by 50%, and to support this, needs to conduct 2 million voluntary adult male circumcisions in 2 years, a nearly impossible goal with surgical methods. Hence, the government embarked upon a pre-safety and pivotal study to test The PrePex™ System, a new device and methodology for rapid adult male circumcision in resource limited settings. Evidence showed the safety and efficacy of the device, as well as the ability to conduct the procedure with no anesthesia, no blood, no sutures and in a standard consultation room.

The government decided to embark upon a controlled, randomized, two arm study comparing the PrePex™ device with the surgical method to have a broader evidence base to support the findings in the pivotal study.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Prevention
HIV
  • Device: PrePex™ device for adult male circumcision
    The PrePex™ device is designed to enable bloodless male circumcision procedure with no anesthesia and no sutures.
    Other Names:
    • The PrePex Device
    • PrePex
    • PrePex™
  • Procedure: Surgical circumcision
    The penis will be surgically circumcised according to one of the WHO recommended circumcision methods as described in the Manual for Male Circumcision under Local Anaesthesia Version 2.5C January 2008
    Other Name: Surgical Circumcision
  • Experimental: PrePex™
    Adult male circumcision by the PrePex™ Device
    Intervention: Device: PrePex™ device for adult male circumcision
  • Active Comparator: Surgical
    Adult male surgical circumcision
    Intervention: Procedure: Surgical circumcision
Mutabazi V, Kaplan SA, Rwamasirabo E, Bitega JP, Ngeruka ML, Savio D, Karema C, Binagwaho A. HIV prevention: male circumcision comparison between a nonsurgical device to a surgical technique in resource-limited settings: a prospective, randomized, nonmasked trial. J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):49-55. doi: 10.1097/QAI.0b013e3182631d69.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
217
April 2011
April 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Ages 21 - 54 years
  • Subject wants to be circumcised
  • Uncircumcised
  • Agrees to be circumcised by any of the study methods, PrePex™ or Surgical as will be determined randomly
  • Able to understand the study procedures and requirements
  • Agrees to abstain sexual intercourse and to keep caution not directly rub the cut area if masturbating, for 8 weeks post removal (9 weeks total).
  • Agrees to return to the health care facility for follow-up visits (or as instructed) after his circumcision that may take up to 8 weeks
  • Subject able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study

Exclusion Criteria:

  • Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the subject from undergoing a circumcision
  • Subject with the following diseases/conditions: phimosis, paraphimosis, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias,epispadias
  • Known bleeding/coagulation abnormality, uncontrolled diabetes
  • Subject who have an abnormal penile anatomy or any penile diseases
  • Subject that to the opinion of the investigator is not a good candidate
  • Subject that refuse to have an HIV test
  • Subject does not agree to anonymous video and photographs of the procedure and follow up.
Male
21 Years to 54 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Rwanda
 
NCT01284088
RMC-01
Yes
Agnes Binagwaho M.D., Ministry of Health, Rwanda
Ministry of Health, Rwanda
Not Provided
Principal Investigator: Agnes Binagwaho, M.D. Ministry of Health, Rwanda
Ministry of Health, Rwanda
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP